Skip to main content
Clinical Trials/JPRN-UMIN000020759
JPRN-UMIN000020759
Completed
未知

Pathological investigation of thromboembolism in the obstetrics and gynecology disorder - Pathological investigation of thromboembolism in the obstetrics and gynecology disorder (PAINT Study)

Department of Obstetrics and Gynecology, Kyushu University Hospital0 sites600 target enrollmentJanuary 27, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Obstetrics and Gynecology, Kyushu University Hospital
Enrollment
600
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 27, 2016
End Date
April 30, 2018
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Department of Obstetrics and Gynecology, Kyushu University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Group A:Patients with the history of thromboembolism 1\.Patients with pregnant. 2\.Patients with post partum within 28 days.Patients within 28 days after surgery (exclude surgeries less than 30 minutes). Group B:Patients without the history of thromboembolism 1\.Patients with pregnant. 2\.Patients with post partum within 28 days.Patients within 28 days after surgery (exclude surgeries less than 30 minutes). 4\.Patients with anti coagulant therapy (eligible if low\-molecular\-weight heparin is available more than 2 weeks before collecting blood). 5\.Patients who initiated the sex steroid hormone therapy within 3 months. Group C:Normal female subjects The information from human genome/gene analysis research"Pathological Investigation of the factor of thromboembolism peculiar in Asian" in Faculty of Nutritional Science,Nakamura Gakuen University is secondarily used. 1\.Patients with hormonal therapy. 2\.Patients with pregnant. 3\.Patients with malignant disease. 4\.Patients with anti coagulant therapy (eligible if low\-molecular\-weight heparin is available more than 2 weeks before collecting blood).

Outcomes

Primary Outcomes

Not specified

Similar Trials